Figure 3.

Flow diagram showing parallel and complementary gene expression classifier and IHC staining used to separate carcinoma into the four major subtypes. Strike thru lines indicate no available IHC. No site of origin classifier was constructed for urothelial as origin site plays no role in treatment decision.